By Matt Harrington, BCBA · Behaviorist Book Club · April 2026 · 12 min read

Navigating Managed Care Peer Reviews for ABA Services: Strategies for Demonstrating Medical Necessity

Overview & Clinical Significance

As the prevalence of autism spectrum disorder diagnoses has increased, so has the demand for applied behavior analysis services funded through insurance and managed care systems. This growth has brought behavior analysts into regular contact with managed care processes that were originally designed for medical and mental health services and may not be well-suited to the unique characteristics of ABA treatment. Among the most consequential of these processes is the peer review, in which a managed care organization evaluates the medical necessity of ABA services to determine whether to authorize, continue, modify, or terminate funding.

The clinical significance of the peer review process cannot be overstated. Authorization decisions directly determine whether a child receives ABA services, how many hours of service they receive, and for how long. A peer review that results in denial or reduction of services can disrupt treatment continuity, delay progress, and cause significant stress for families. Conversely, a well-navigated peer review that results in appropriate authorization ensures that the child continues to receive the evidence-based treatment they need.

Papatola and Lustig's (2016) article provides guidance specifically designed to help clinicians navigate this process more effectively. The peer review conversation is essentially a clinical argument: the behavior analyst must make a clear, compelling case that ABA services are medically necessary for a specific individual, that the proposed treatment plan is appropriate, and that continued services are justified by the clinical data. Making this argument effectively requires not only strong clinical skills but also an understanding of how managed care systems evaluate claims and what information reviewers need to make favorable decisions.

Many behavior analysts find the peer review process frustrating because it requires them to justify their clinical recommendations to reviewers who may have limited understanding of ABA methodology. However, this frustration is more productive when channeled into preparation. Behavior analysts who understand the peer review process, prepare thoroughly, and communicate their clinical rationale clearly are far more likely to obtain favorable authorization decisions than those who approach the process unprepared or adversarially.

The stakes extend beyond individual clients. The cumulative effect of how behavior analysts perform in peer reviews shapes managed care organizations' perceptions of ABA as a treatment modality. When behavior analysts consistently present clear, data-driven justifications for services, they build credibility for the field as a whole. When they present disorganized, jargon-heavy, or poorly supported arguments, they reinforce skepticism about the value and necessity of ABA services.

Background & Context

Managed care peer reviews emerged from the healthcare system's need to control costs while ensuring that patients receive medically necessary services. In the context of ABA services for autism, peer reviews typically occur when an insurance company evaluates initial authorization requests, renewal requests for ongoing services, or requests for changes in service intensity. The reviewer is usually a licensed healthcare professional, often a physician, psychologist, or sometimes a behavior analyst, who evaluates the clinical information provided by the treating clinician against the managed care organization's criteria for medical necessity.

The concept of medical necessity is central to the peer review process but is defined differently across managed care organizations and state laws. Generally, a service is considered medically necessary if it is required to diagnose or treat a medical condition, is consistent with generally accepted standards of care, is the most appropriate and least restrictive level of care, and is expected to produce clinically meaningful outcomes. For ABA services, this typically means demonstrating that the child has a diagnosed condition that responds to behavioral treatment, that the proposed treatment plan is based on a thorough assessment, that the intensity of services is justified by the child's needs, and that progress data support the continued necessity of treatment.

The challenge for behavior analysts is that managed care reviewers may not be familiar with ABA-specific concepts such as functional behavior assessment, verbal operant analysis, or reinforcement-based teaching procedures. They may evaluate ABA claims using frameworks developed for medical or psychotherapeutic interventions, which emphasize different outcome measures and different criteria for treatment intensity and duration. This mismatch creates a communication burden for the behavior analyst, who must translate behavioral concepts into language that the reviewer can evaluate within their existing framework.

The regulatory landscape surrounding ABA insurance coverage has evolved significantly. Many states have enacted autism insurance mandates that require coverage of ABA services, but these mandates vary in their specifics regarding age limits, dollar caps, hour limits, and definitions of covered services. Behavior analysts must be familiar with the laws in their state and understand how those laws interact with managed care organizations' authorization processes.

The growth of ABA services has also led some managed care organizations to develop ABA-specific utilization review criteria, which can be both a benefit and a challenge. ABA-specific criteria may be more aligned with how behavioral services actually work, but they may also impose restrictions that do not reflect best clinical practice. Behavior analysts need to understand these criteria and be prepared to advocate for their clients when clinical judgment conflicts with utilization review guidelines.

Clinical Implications

Preparing for a managed care peer review is a clinical activity that deserves the same careful planning as any other aspect of treatment. The clinical implications begin with documentation practices. Every peer review evaluates the clinical documentation that the behavior analyst has produced, including assessment reports, treatment plans, progress notes, and data summaries. If this documentation is incomplete, poorly organized, or lacking in clinical specificity, the peer review starts at a disadvantage regardless of the quality of the actual clinical work.

Effective documentation for peer review purposes tells a coherent clinical story. It begins with a thorough assessment that establishes the baseline: what are the child's current skill deficits and behavioral excesses, how were they assessed, and how do they affect the child's functioning? It continues with a treatment plan that logically follows from the assessment: what specific targets have been selected, why are they clinically important, what procedures will be used, and what is the expected timeline for progress? And it provides ongoing data that demonstrate whether the treatment plan is working: are targeted skills increasing, are problem behaviors decreasing, and are these changes clinically meaningful?

One of the most critical clinical implications involves how behavior analysts present outcome data to reviewers. Raw data sheets and technical behavior graphs may be standard within ABA practice but can be impenetrable to a reviewer without behavioral training. Converting data into formats that are accessible to non-behavioral clinicians, such as standardized scores, functional outcome measures, or clear before-and-after comparisons with plain-language explanations, significantly increases the likelihood that the reviewer will understand and be persuaded by the clinical picture.

The peer review conversation itself requires specific preparation. Behavior analysts should anticipate the reviewer's questions and prepare clear, concise responses. Common questions include why ABA services are more appropriate than other interventions, why the requested number of hours is necessary, what progress has been made, what happens if services are reduced or discontinued, and what the plan is for transitioning to less intensive services. Having data-supported answers to these questions ready before the conversation begins makes the peer review significantly more efficient and effective.

Clinical implications also extend to goal writing. Goals that are written in ABA-specific language without reference to functional outcomes may not communicate their clinical significance to a managed care reviewer. A goal like "the client will mand for preferred items with 80 percent independence across five consecutive sessions" is behaviorally precise but may not convey clinical necessity to a non-behavioral reviewer. Reframing the same goal as "the client will develop functional communication to request needs independently, reducing reliance on maladaptive behavior as a communication strategy" connects the behavioral target to a clinical outcome that the reviewer can evaluate.

Finally, the clinical implications include knowing when and how to appeal an unfavorable decision. If a peer review results in denial or reduction of services, behavior analysts should understand the appeals process, the timelines involved, and what additional information might be persuasive. Many denials are overturned on appeal when additional clinical information is provided.

Ethical Considerations

The peer review process raises several ethical considerations that behavior analysts must navigate carefully. Code 2.01 (Providing Effective Treatment) is directly relevant because authorization decisions determine whether clients can access the treatment they need. Behavior analysts have an ethical obligation to advocate for appropriate services through the peer review process, presenting the strongest possible case for the services their clients require.

Code 2.13 (Accuracy in Billing and Reporting) requires behavior analysts to be honest and accurate in their representations to managed care organizations. While advocacy is important, it must be grounded in accurate clinical data. Inflating symptom severity, exaggerating the need for services, or misrepresenting progress data to obtain authorization would violate this standard. The ethical imperative is to present the clinical picture accurately and completely, trusting that an honest presentation of a genuine clinical need will support the authorization request.

Code 2.09 (Involving Clients and Stakeholders) requires that families be involved in the service delivery process, which includes keeping them informed about authorization decisions and their implications. When a peer review results in a reduction or denial of services, families need clear, honest communication about what happened, what the behavior analyst is doing to address the situation, and what options are available. Families should also be informed of their right to appeal and supported in exercising that right if they choose to do so.

Code 3.01 (Behavior-Analytic Assessment) and Code 3.12 (Advocating for Appropriate Services) together establish that behavior analysts should conduct thorough assessments that support treatment recommendations and advocate for the services that the assessment indicates are necessary. When a managed care reviewer questions the necessity of services, the behavior analyst's assessment data should provide the foundation for their advocacy.

There is an ethical tension between accepting managed care decisions and advocating for clients. While behavior analysts should work within established systems and processes, they also have an obligation to advocate when those systems produce decisions that are not in the client's best interest. This advocacy should be conducted through appropriate channels (appeals, external reviews, regulatory complaints) rather than through adversarial or unprofessional behavior during the peer review itself.

Code 1.04 (Integrity) requires behavior analysts to be straightforward and professional in all interactions, including those with managed care reviewers. Even when a reviewer's questions feel inappropriate or their decision seems unjustified, the behavior analyst must maintain professional composure and respond with factual, clinical information. Emotional or adversarial responses undermine the clinical argument and damage the professional relationship with the managed care organization.

There is also an ethical consideration related to ongoing competency. The managed care landscape evolves continuously, with changing authorization criteria, new review processes, and shifting regulatory requirements. Behavior analysts who work within managed care systems have an ethical obligation to stay current with these changes and to develop the skills needed to navigate them effectively. This includes understanding insurance law, utilization review criteria, and the appeals process.

Assessment & Decision-Making

Preparing for a managed care peer review involves a systematic assessment of your clinical documentation, your data, and your ability to communicate the clinical rationale for services. Begin by reviewing your documentation through the eyes of someone unfamiliar with ABA. Does your assessment report clearly establish the client's needs in terms that any healthcare professional can understand? Does your treatment plan logically connect assessment findings to treatment targets? Do your progress reports demonstrate measurable, clinically meaningful progress?

Decision-making about how to present clinical information should be guided by the principle of clarity. For each piece of clinical information you plan to share, ask: Will this help the reviewer understand why services are necessary? If the answer is yes, include it in a format the reviewer can understand. If the information is clinically important but technically complex, prepare a plain-language explanation that preserves the essential meaning.

Assess the strength of your clinical argument by anticipating counterarguments. A skilled reviewer might ask: Why can't these skills be taught in fewer hours? Why hasn't the child made more progress given the intensity of services? Why is ABA more appropriate than speech therapy or occupational therapy alone? What is the plan for reducing service intensity? Having prepared, data-supported responses to these questions strengthens your position significantly.

Decision-making about goal selection and presentation is particularly important. Select goals for the peer review discussion that are most clearly connected to functional outcomes and medical necessity. Goals that address safety (reducing dangerous behavior), communication (developing functional communication to replace maladaptive behavior), and daily living skills (increasing independence in self-care, academic readiness, or social participation) are generally most persuasive because they connect directly to the child's health and functioning.

When deciding how to present data, consider the reviewer's likely background. Physicians and psychologists are accustomed to standardized scores, norm-referenced measures, and functional outcome ratings. If you can supplement your behavioral data with these types of measures, your argument becomes more accessible. This does not mean abandoning behavioral data but rather presenting it alongside measures that the reviewer is familiar with.

Assess your communication style and adjust it for the peer review context. The conversational style that works well in a team meeting with colleagues is different from the clinical argumentation style needed in a peer review. Practice presenting your case concisely, focusing on the most relevant clinical information and avoiding tangential details. A focused, confident presentation is more persuasive than an exhaustive data dump.

Finally, make a deliberate decision about your stance going into the review. The most effective stance is collaborative rather than adversarial. The reviewer is not your enemy; they are a professional tasked with evaluating medical necessity. Approaching the conversation as a collaborative clinical discussion, where you are providing the information the reviewer needs to make an informed decision, produces better outcomes than an oppositional approach.

What This Means for Your Practice

Build peer review preparation into your routine clinical workflow rather than treating it as an emergency when authorization is due. Maintain documentation that is always peer-review-ready by writing assessment reports, treatment plans, and progress notes with the understanding that they may be reviewed by someone outside your field. This means including plain-language explanations alongside technical terminology, connecting every treatment target to a functional outcome, and presenting data in formats that are accessible to non-behavioral clinicians.

Develop a peer review preparation checklist that you follow before every authorization request. This checklist should include: reviewing the managed care organization's specific authorization criteria, ensuring that your documentation addresses each criterion, preparing a concise clinical summary that connects assessment findings to treatment targets to progress data, and anticipating the reviewer's likely questions.

Practice your peer review presentation. Many behavior analysts experience anxiety during peer reviews because they feel unprepared for questions or unsure how to present their clinical case. Practicing with a colleague, particularly one who can play the role of a skeptical reviewer, builds confidence and helps identify weak points in your argument before the actual review.

Know your rights and your client's rights within the managed care process. Understand the appeals process for unfavorable decisions. Familiarize yourself with your state's insurance laws regarding ABA coverage. When a denial occurs, take systematic action: document the denial, notify the family, initiate the appeal, and provide any additional clinical information that addresses the reviewer's stated concerns.